Literature DB >> 33955792

Is rTMS Ready for Primetime?

Gin S Malhi1,2, Erica Bell1,2, Tim Outhred1,2, Ajeet B Singh3, Malcom Hopwood4, Roger Mulder5, Darryl Bassett6, Zola Mannie1,2,7.   

Abstract

Entities:  

Keywords:  ECT; depression; mood disorders; rTMS; treatments

Mesh：

Year:  2021        PMID： 33955792      PMCID： PMC8573708          DOI： 10.1177/07067437211016238

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  16 in total

Review 1.  The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?

Authors:  Kyle M Fargen; Donald Frei; David Fiorella; Cameron G McDougall; Philip M Myers; Joshua A Hirsch; J Mocco
Journal:  J Neurointerv Surg       Date:  2012-07-04       Impact factor: 5.836

Review 2.  Depression.

Authors:  Gin S Malhi; J John Mann
Journal:  Lancet       Date:  2018-11-02       Impact factor: 79.321

3.  Treatment-resistant depression: problematic illness or a problem in our approach?

Authors:  Gin S Malhi; Pritha Das; Zola Mannie; Lauren Irwin
Journal:  Br J Psychiatry       Date:  2019-01       Impact factor: 9.319

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

Authors:  Roumen V Milev; Peter Giacobbe; Sidney H Kennedy; Daniel M Blumberger; Zafiris J Daskalakis; Jonathan Downar; Mandana Modirrousta; Simon Patry; Fidel Vila-Rodriguez; Raymond W Lam; Glenda M MacQueen; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

5.  Excess Significance Bias in Repetitive Transcranial Magnetic Stimulation Literature for Neuropsychiatric Disorders.

Authors:  Ali Amad; Renaud Jardri; Chloé Rousseau; Yann Larochelle; John P A Ioannidis; Florian Naudet
Journal:  Psychother Psychosom       Date:  2019-10-07       Impact factor: 17.659

6.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

Review 7.  Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-03-01

8.  Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial.

Authors:  U Herwig; A J Fallgatter; J Höppner; G W Eschweiler; M Kron; G Hajak; F Padberg; A Naderi-Heiden; B Abler; P Eichhammer; N Grossheinrich; B Hay; T Kammer; B Langguth; C Laske; C Plewnia; M M Richter; M Schulz; S Unterecker; A Zinke; M Spitzer; C Schönfeldt-Lecuona
Journal:  Br J Psychiatry       Date:  2007-11       Impact factor: 9.319

Review 9.  Is treatment-resistant depression a useful concept?

Authors:  Gin S Malhi; Yulisha Byrow
Journal:  Evid Based Ment Health       Date:  2016-01-14

Review 10.  The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary.

Authors:  Gin S Malhi; Erica Bell; Ajeet B Singh; Darryl Bassett; Michael Berk; Philip Boyce; Richard Bryant; Michael Gitlin; Amber Hamilton; Philip Hazell; Malcolm Hopwood; Bill Lyndon; Roger S McIntyre; Grace Morris; Roger Mulder; Richard Porter; Lakshmi N Yatham; Allan Young; Greg Murray
Journal:  Bipolar Disord       Date:  2020-12       Impact factor: 6.744
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.